NCT00311493View on ClinicalTrials.gov

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

PHASE4CompletedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

February 28, 2006

Conditions

Encephalitis, Tick-Borne

Interventions

BIOLOGICAL

Tick-Borne Encephalitis vaccine

Trial Locations (1)

Unknown

Regensburg

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY

NCT00311493 - Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults | Biotech Hunter | Biotech Hunter